Showing 1 - 6 results of 6 for search 'Vivek Roy', query time: 0.01s Refine Results
  1. 1
    Primary Cutaneous T-Cell Lymphoblastic Lymphoma: Case Report and Literature Review

    Primary Cutaneous T-Cell Lymphoblastic Lymphoma: Case Report and Literature Review by Sharad Khurana, Manuel Beltran, Liuyan Jiang, Ernesto Ayala, Vivek Roy

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Deciphering chromate tolerance and reduction ability of an indigenous Bacillus strain isolated from polluted pond sludge for chromium bioremediation

    Deciphering chromate tolerance and reduction ability of an indigenous Bacillus strain isolated from polluted pond sludge for chromium bioremediation by Samarpita Adhikary, Barnan Kumar Saha, Vivek Roy, Jayanti Saha, Ayon Pal

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review

    Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review by Ricardo D. Parrondo, Vivek Roy, Taimur Sher, Victoria Alegria, Asher A. Chanan-Khan, Sikander Ailawadhi

    Published 2020-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience by Ricardo D. Parrondo, Saurav Das, Hanna Sledge, Leif Bergsagel, Rafael Fonseca, Nelson Leung, Prashant Kapoor, Morie Gertz, Francis Buadi, Angela Dispenzieri, Jamie Elliott, Andre Fernandez, Caitlin Flott, Asher A. Chanan-Khan, Vivek Roy, Sikander Ailawadhi

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

    Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations by Anmol Baranwal, Kimberly J. Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich, Caner Saygin, Mariam Nawas, Talha Badar, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Vivek Roy, James M. Foran, Hemant S. Murthy, Madiha Iqbal, Jeanne Palmer, Lisa Z. Sproat, Saurabh Chhabra, Nandita Khera, Mehrdad Hefazi, Abhishek Mangaonkar, William Hogan, Mark Litzow, Hassan Alkhateeb, Ayalew Tefferi, Chung Hoow Kok, Guru Subramanian Guru Murthy, Anand Patel, Ashish Bajel, Devendra K. Hiwase, Mithun Vinod Shah

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes

    Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes by Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, Nadine Abdallah, P. Leif Bergsagel, Moritz Binder, Francis Buadi, Saurabh Chhabra, Joselle Cook, David Dingli, Angela Dispenzieri, Morie A. Gertz, Wilson Gonsalves, Suzanne Hayman, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, Yi Lin, Eli Muchtar, Ricardo Parrondo, Vivek Roy, Taimur Sher, Mustaqeem Siddiqui, Rahma Warsame, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Michelle Rogers, Udit Yadav, J. Erin Wiedmeier-Nutor, Linda B. Baughn, S. Vincent Rajkumar, Rafael Fonseca, Sikander Ailawadhi, Shaji Kumar

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: